These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes. Xie W, Wang X, Du W, Liu W, Qin X, Huang S. Cytometry A; 2010 Sep 27; 77(9):840-8. PubMed ID: 20662087 [Abstract] [Full Text] [Related]
8. [STAT5 phosphorylation in CD34(+)CD38(-)CD123(+) bone marrow cells of the patients with myelodysplastic syndrome]. Liu BN, Fu R, Wang HQ, Li LJ, Yue LZ, Ruan EB, Qu W, Liang Y, Wang GJ, Wang XM, Liu H, Wu YH, Song J, Xing LM, Guan J, Wang J, Shao ZH. Zhonghua Xue Ye Xue Za Zhi; 2012 Jun 27; 33(6):480-3. PubMed ID: 22967386 [Abstract] [Full Text] [Related]
11. Pretreatment CD34+/CD38- Cell Burden as Prognostic Factor in Myelodysplastic Syndrome Patients Receiving Allogeneic Stem Cell Transplantation. Jentzsch M, Geus U, Grimm J, Vucinic V, Pönisch W, Franke GN, Behre G, Niederwieser D, Schwind S. Biol Blood Marrow Transplant; 2019 Aug 27; 25(8):1560-1566. PubMed ID: 30928626 [Abstract] [Full Text] [Related]
12. Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes. Dong X, Han Y, Liu Y, Yang L, Niu H, Yan L, Liu C, Shao Z, Xing L, Wang H. Asia Pac J Clin Oncol; 2022 Apr 27; 18(2):e119-e128. PubMed ID: 34152084 [Abstract] [Full Text] [Related]
13. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia. Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H. Arch Med Res; 2014 May 27; 45(4):343-50. PubMed ID: 24751333 [Abstract] [Full Text] [Related]
14. Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies. Florian S, Sonneck K, Hauswirth AW, Krauth MT, Schernthaner GH, Sperr WR, Valent P. Leuk Lymphoma; 2006 Feb 27; 47(2):207-22. PubMed ID: 16321850 [Abstract] [Full Text] [Related]
15. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia]. Dao FT, Yang L, Wang YZ, Chang Y, Jiang Q, Jiang H, Liu YR, Huang XJ, Qin YZ. Zhonghua Xue Ye Xue Za Zhi; 2019 Oct 14; 40(10):831-836. PubMed ID: 31775482 [Abstract] [Full Text] [Related]
16. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L, Hellström-Lindberg E, Kock Y, Elmhorn-Rosenborg A, Ost A. Eur J Haematol; 1996 Mar 14; 56(3):124-9. PubMed ID: 8598230 [Abstract] [Full Text] [Related]
17. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Blood; 2002 Jul 01; 100(1):259-67. PubMed ID: 12070035 [Abstract] [Full Text] [Related]
18. Expression of CD123 and CD114 on the bone marrow cells of patients with myelodysplastic syndrome. Yue LZ, Fu R, Wang HQ, Li LJ, Hu HR, Fu L, Shao ZH. Chin Med J (Engl); 2010 Aug 05; 123(15):2034-7. PubMed ID: 20819538 [Abstract] [Full Text] [Related]
19. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes. Maratheftis CI, Bolaraki PE, Voulgarelis M. Am J Hematol; 2007 Oct 05; 82(10):887-92. PubMed ID: 17570514 [Abstract] [Full Text] [Related]
20. CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia. Heo SK, Noh EK, Ju LJ, Sung JY, Jeong YK, Cheon J, Koh SJ, Min YJ, Choi Y, Jo JC. BMC Cancer; 2020 Apr 06; 20(1):285. PubMed ID: 32252668 [Abstract] [Full Text] [Related] Page: [Next] [New Search]